166 related articles for article (PubMed ID: 21138735)
1. Chemokine-related gene expression in the brain following ischemic stroke: no role for CXCR2 in outcome.
Brait VH; Rivera J; Broughton BR; Lee S; Drummond GR; Sobey CG
Brain Res; 2011 Feb; 1372():169-79. PubMed ID: 21138735
[TBL] [Abstract][Full Text] [Related]
2. CXCR2 antagonists block the N-Ac-PGP-induced neutrophil influx in the airways of mice, but not the production of the chemokine CXCL1.
Braber S; Overbeek SA; Koelink PJ; Henricks PA; Zaman GJ; Garssen J; Kraneveld AD; Folkerts G
Eur J Pharmacol; 2011 Oct; 668(3):443-9. PubMed ID: 21458445
[TBL] [Abstract][Full Text] [Related]
3. CXCR2 antagonist attenuates neutrophil transmigration into brain in a murine model of LPS induced neuroinflammation.
Wu F; Chen X; Zhai L; Wang H; Sun M; Song C; Wang T; Qian Z
Biochem Biophys Res Commun; 2020 Aug; 529(3):839-845. PubMed ID: 32616311
[TBL] [Abstract][Full Text] [Related]
4. CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis.
Mehrad B; Strieter RM; Moore TA; Tsai WC; Lira SA; Standiford TJ
J Immunol; 1999 Dec; 163(11):6086-94. PubMed ID: 10570298
[TBL] [Abstract][Full Text] [Related]
5. Alkali-induced corneal neovascularization is independent of CXCR2-mediated neutrophil infiltration.
Lu P; Li L; Mukaida N; Zhang X
Cornea; 2007 Feb; 26(2):199-206. PubMed ID: 17251813
[TBL] [Abstract][Full Text] [Related]
6. Neutrophils promote experimental choroidal neovascularization.
Zhou J; Pham L; Zhang N; He S; Gamulescu MA; Spee C; Ryan SJ; Hinton DR
Mol Vis; 2005 Jun; 11():414-24. PubMed ID: 15988410
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of the chemokine receptor CXCR2 attenuates neutrophil infiltration and cortical damage following closed head injury.
Semple BD; Bye N; Ziebell JM; Morganti-Kossmann MC
Neurobiol Dis; 2010 Nov; 40(2):394-403. PubMed ID: 20621186
[TBL] [Abstract][Full Text] [Related]
8. Role of Neutrophils in Exacerbation of Brain Injury After Focal Cerebral Ischemia in Hyperlipidemic Mice.
Herz J; Sabellek P; Lane TE; Gunzer M; Hermann DM; Doeppner TR
Stroke; 2015 Oct; 46(10):2916-25. PubMed ID: 26337969
[TBL] [Abstract][Full Text] [Related]
9. The effects of the selective and non-peptide CXCR2 receptor antagonist SB225002 on acute and long-lasting models of nociception in mice.
Manjavachi MN; Quintão NL; Campos MM; Deschamps IK; Yunes RA; Nunes RJ; Leal PC; Calixto JB
Eur J Pain; 2010 Jan; 14(1):23-31. PubMed ID: 19264522
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin antagonizes CD40L secretion, CXC chemokine formation, and pulmonary infiltration of neutrophils in abdominal sepsis.
Zhang S; Rahman M; Zhang S; Qi Z; Thorlacius H
J Leukoc Biol; 2011 May; 89(5):735-42. PubMed ID: 21330348
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
Luo Y; Yin W; Signore AP; Zhang F; Hong Z; Wang S; Graham SH; Chen J
J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667
[TBL] [Abstract][Full Text] [Related]
12. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
13. Enhanced pulmonary expression of CXC chemokines during hepatic ischemia/reperfusion-induced lung injury in mice.
Yoshidome H; Lentsch AB; Cheadle WG; Miller FN; Edwards MJ
J Surg Res; 1999 Jan; 81(1):33-7. PubMed ID: 9889054
[TBL] [Abstract][Full Text] [Related]
14. Strong neuroprotection with a novel platinum nanoparticle against ischemic stroke- and tissue plasminogen activator-related brain damages in mice.
Takamiya M; Miyamoto Y; Yamashita T; Deguchi K; Ohta Y; Abe K
Neuroscience; 2012 Sep; 221():47-55. PubMed ID: 22766232
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Kupffer cells reduced CXC chemokine production and liver injury.
Mosher B; Dean R; Harkema J; Remick D; Palma J; Crockett E
J Surg Res; 2001 Aug; 99(2):201-10. PubMed ID: 11469888
[TBL] [Abstract][Full Text] [Related]
16. Effects of the PDE5-inhibitor vardenafil in a mouse stroke model.
Royl G; Balkaya M; Lehmann S; Lehnardt S; Stohlmann K; Lindauer U; Endres M; Dirnagl U; Meisel A
Brain Res; 2009 Apr; 1265():148-57. PubMed ID: 19368809
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effect of erythropoietin, and role of metallothionein-1 and -2, in permanent focal cerebral ischemia.
Wakida K; Shimazawa M; Hozumi I; Satoh M; Nagase H; Inuzuka T; Hara H
Neuroscience; 2007 Aug; 148(1):105-14. PubMed ID: 17624681
[TBL] [Abstract][Full Text] [Related]
18. Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat.
Dohare P; Garg P; Jain V; Nath C; Ray M
Behav Brain Res; 2008 Nov; 193(2):289-97. PubMed ID: 18611416
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells.
Chen Y; Hallenbeck JM; Ruetzler C; Bol D; Thomas K; Berman NE; Vogel SN
J Cereb Blood Flow Metab; 2003 Jun; 23(6):748-55. PubMed ID: 12796723
[TBL] [Abstract][Full Text] [Related]
20. Chemokine receptor antagonist peptide, viral MIP-II, protects the brain against focal cerebral ischemia in mice.
Takami S; Minami M; Nagata I; Namura S; Satoh M
J Cereb Blood Flow Metab; 2001 Dec; 21(12):1430-5. PubMed ID: 11740204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
